{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:05:42Z","timestamp":1771063542257,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.nucmedbio.2011.02.015","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T23:20:23Z","timestamp":1303514423000},"page":"1011-1018","source":"Crossref","is-referenced-by-count":40,"title":["Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging"],"prefix":"10.1016","volume":"38","author":[{"given":"Kentaro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Suwada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Oshikiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ashino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Dozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Minamizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.nucmedbio.2011.02.015_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","article-title":"Bisphosphonates: clinical experience","volume":"9","author":"Coleman","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1148\/rg.232025103","article-title":"Radionuclide bone imaging: an illustrative review","volume":"23","author":"Love","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0020","first-page":"744","article-title":"Technetium-99m-methylene diphosphonate \u2014 a superior agent for skeletal imaging: comparison with other technetium complexes","volume":"16","author":"Subramanian","year":"1975","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02985050","article-title":"Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer","volume":"19","author":"Abe","year":"2005","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0030","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0035","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1359\/jbmr.2003.18.12.2206","article-title":"F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management","volume":"18","author":"Hetzel","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0040","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0045","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.1999.17.8.2381","article-title":"Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography","volume":"17","author":"Schirrmeister","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00259-009-1181-2","article-title":"Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET\/CT","volume":"36","author":"Kruger","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0055","first-page":"1623","article-title":"Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET","volume":"40","author":"Schirrmeister","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0020-708X(60)90052-1","article-title":"A positron cow","volume":"8","author":"Gleason","year":"1960","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0020-708X(61)90034-5","article-title":"An improved gallium-68 cow","volume":"12","author":"Greene","year":"1961","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0070","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00259-007-0387-4","article-title":"The 68Ge\/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?","volume":"34","author":"Breeman","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cmmi.232","article-title":"68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals","volume":"3","author":"Fani","year":"2008","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0080","first-page":"605","article-title":"Bone scanning with gallium-68: a carrier effect","volume":"6","author":"Hayes","year":"1965","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0020-708X(75)90116-7","article-title":"Investigation of 68Ga-tripolyphosphate as a potential bone-scanning agent","volume":"26","author":"Goulet","year":"1975","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0090","first-page":"1003","article-title":"New 68Ga-labeled skeletal-imaging agents for positron scintigraphy","volume":"17","author":"Dewanjee","year":"1976","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejpb.2007.05.015","article-title":"Preparation and pre-vivo evaluation of no-carrier-added, carrier-added and cross-complexed [68Ga]-EDTMP formulations","volume":"68","author":"Toegel","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nucmedbio.2007.03.002","article-title":"Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP","volume":"34","author":"Mitterhauser","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1039\/B512310K","article-title":"\u2018Magic bullets\u2019 for bone diseases: progress in rational design of bone-seeking medicinal agents","volume":"36","author":"Zhang","year":"2007","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/bc010074f","article-title":"NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67\/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors","volume":"13","author":"Eisenwiener","year":"2002","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0115","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0960-894X(00)00413-3","article-title":"A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling","volume":"10","author":"Eisenwiener","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0120","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1021\/jm060398v","article-title":"Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis","volume":"49","author":"Vachal","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0125","first-page":"2587","article-title":"Prostate cancer cells\u2013osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0130","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.1158\/0008-5472.CAN-05-0540","article-title":"The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer","volume":"65","author":"Miwa","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0135","first-page":"5652","article-title":"Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/bc900443a","article-title":"Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals","volume":"21","author":"Ferreira","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/bc700341x","article-title":"Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature","volume":"19","author":"Velikyan","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0150","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2967\/jnumed.109.068858","article-title":"Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner","volume":"51","author":"Disselhorst","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.02.015_bb0155","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00259-009-1355-y","article-title":"PET\/CT imaging of osteoblastic bone metastases with 68Ga-bisphosphonates: first human study","volume":"37","author":"Fellner","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T06:54:55Z","timestamp":1560149695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805111000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0969805111000527"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.02.015","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}